Literature DB >> 5420208

Effect of controlled oxygen therapy on arterial blood gases in acute respiratory failure.

D A Warrell, R H Edwards, S Godfrey, N L Jones.   

Abstract

Seven patients in acute exacerbation of chronic respiratory failure were given 24.5% and later 28% oxygen through Ventimasks. The mean increases in arterial PO(2) were 11 and 21 mm. Hg while breathing 24.5% and 28% oxygen respectively compared with control values while breathing air. Associated increases in arterial PCO(2) were 4 and 8 mm. Hg, respectively. In five of the patients these increases in inspired oxygen concentration resulted in useful increases in tissue oxygen supply without significant deterioration in ventilation, but in two patients arterial PCO(2) rose excessively and artificial ventilation was required.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5420208      PMCID: PMC1700518          DOI: 10.1136/bmj.2.5707.452

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  ARTERIAL HYPOXAEMIA, SERUM ACTIVITIES OF GO-T, GP-T AND LDH, AND CENTRILOBULAR LIVER CELL NECROSIS IN PULMONARY INSUFFICIENCY.

Authors:  H E REFSUM
Journal:  Clin Sci       Date:  1963-12       Impact factor: 6.124

2.  SEVERITY OF RESPIRATORY FAILURE. ARTERIAL BLOOD-GASES IN UNTREATED PATIENTS.

Authors:  M W MCNICOL; E J CAMPBELL
Journal:  Lancet       Date:  1965-02-13       Impact factor: 79.321

3.  Respiratory failure: the relation between oxygen concentrations of inspired air and arterial blood.

Authors:  E J CAMPBELL
Journal:  Lancet       Date:  1960-07-02       Impact factor: 79.321

4.  Simple rapid methods of estimating arterial and mixed venous pCO2.

Authors:  E J CAMPBELL; J B HOWELL
Journal:  Br Med J       Date:  1960-02-13

5.  Choice of method for administration of oxygen.

Authors:  I D Green
Journal:  Br Med J       Date:  1967-09-02

6.  An evaluation of oxygen therapy equipment. Experimental study of various devices on the human subject.

Authors:  D W Bethune; J M Collis
Journal:  Thorax       Date:  1967-05       Impact factor: 9.139

7.  Oxygen therapy in respiratory failure.

Authors:  J C Mithoefer; M S Karetzky; G D Mead
Journal:  N Engl J Med       Date:  1967-11-02       Impact factor: 91.245

8.  Effect of oxygen breathing on distribution of pulmonary blood flow in chronic obstructive lung disease.

Authors:  J Lee; J Read
Journal:  Am Rev Respir Dis       Date:  1967-12

9.  Effect of oxygen administration by a Venturi apparatus on arterial blood gas values in patients with respiratory failure.

Authors:  M M Schiff; D Massaro
Journal:  N Engl J Med       Date:  1967-11-02       Impact factor: 91.245

10.  Blood lactate levels and some blood acidbase changes in respiratory failure and their significance in oxygen induced-respiratory depression.

Authors:  R W PENMAN
Journal:  Clin Sci       Date:  1962-08       Impact factor: 6.124

View more
  6 in total

Review 1.  Emergency oxygen therapy for the COPD patient.

Authors:  R Murphy; P Driscoll; R O'Driscoll
Journal:  Emerg Med J       Date:  2001-09       Impact factor: 2.740

2.  Control of breathing in disease.

Authors:  S J Semple
Journal:  Proc R Soc Med       Date:  1975-04

Review 3.  Management of an acute exacerbation of copd: are we ignoring the evidence?

Authors:  M K Johnson; R D Stevenson
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

4.  Moran Campbell and clinical science.

Authors:  G J Gibson
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

5.  Randomized controlled trial of high concentration oxygen in suspected community-acquired pneumonia.

Authors:  Meme Wijesinghe; Kyle Perrin; Bridget Healy; Mark Weatherall; Richard Beasley
Journal:  J R Soc Med       Date:  2012-04-24       Impact factor: 5.344

Review 6.  The importance of the ionic product for water to understand the physiology of the acid-base balance in humans.

Authors:  María M Adeva-Andany; Natalia Carneiro-Freire; Cristóbal Donapetry-García; Eva Rañal-Muíño; Yosua López-Pereiro
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.